The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lundberg Magnus since year 2005.
The trader's CIK number is 1235944.
At the time of this reporting, Lundberg Magnus is the Director of Onyx Pharmaceuticals Inc .
(stock ticker symbol ONXX).
See this page for all insider trading activities at Onyx Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-04-11||ONXX||Onyx Pharmaceuticals Inc||Sale||10,000||96.00||960,000|
|2013-04-11||ONXX||Onyx Pharmaceuticals Inc||Option Ex||10,000||16.28||162,800|
|2013-04-01||ONXX||Onyx Pharmaceuticals Inc||Sale||10,000||92.00||920,000|
|2013-04-01||ONXX||Onyx Pharmaceuticals Inc||Option Ex||10,000||23.70||237,000|
|2013-03-11||ONXX||Onyx Pharmaceuticals Inc||Sale||5,000||88.00||440,000|
|2013-03-11||ONXX||Onyx Pharmaceuticals Inc||Option Ex||5,000||38.85||194,250|
|2012-06-25||ONXX||Onyx Pharmaceuticals Inc||Sale||5,000||65.18||325,875|
|2012-06-25||ONXX||Onyx Pharmaceuticals Inc||Option Ex||5,000||12.11||60,550|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lundberg Magnus (Director of Onyx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.